Nikon Corp. announced on August 3 the financial results for the first quarter ending on June 30, reporting that the total revenue for the period gained a 0.6% year-on-year to 170.3 billion yen, profit in operation declined 31.1% to 12.4 billion yen and net profit down 39.5% to 8.89 billion yen. In the Imaging Products segment, sales of mid-class cameras such as the D7500, a digital SLR camera released in June this year were firm, with unit sales increasing significantly in the U.S. Accordingly, the performance in revenue and operating profit exceeded the planned targets, but compared to the last year, a decease in revenue and operating profit was recorded due to a product mix change caused by the stagnant demand for the D5 and the D500. The company sold 720,000 units of interchangeable-lens cameras, 1.08 million units of interchangeable lenses and 770,000 compact digital cameras. The company said the unit sales of compact digital cameras declined but the average unit price rose about 30%.
Japan's leading printer and photocopier maker Konica Minolta Inc. announced at the company will be acquiring Ambry Genetic Corp. - a US diagnostic company, in a deal valued at up to USD 1 billion. This is one of the largest deals for Konica Minolta and the company will jointly carry out the acquisition with the funds provided by Innovation Network Corp of Japan. Konica Minolta, which has a market value of around $4 billion, will account for 60 percent of the investment and the Innovation Network Corp of Japan (INCJ) will provide for the remaining 40 percent. Both the companies intend to enter into the precision medicine segment which is expected to have a great potential for the treatment of cancer. KMI has its own diagnostic technique, utilising a High Sensitive Tissue Testing (HSTT) technology, while Ambry excels in genetic tests for breast, colon and cancers, heart and respiratory diseases, etc. Further, the company will combine its HSTT technology and Ambry's genetic diagnostic technology to offer high-standard cancer diagnostic services and aid the development of new reagents which will help produce new medicines. Talking about the acquisition, Shoei Yamana - Chief Executive Officer of Konica Minolta Inc., said, “Together with Ambry, we will have the most comprehensive set of diagnostic technologies for mapping an individual's genetic and biochemical makeup." The companies expect to complete the necessary procedure for the deal by the end of October, 2017 and post which, Ambry will become a subsidiary of KMI while Ambry's business will be continued in the US.
Nikon Corp. has released a new FX-format telephoto zoom lens, AF-P Nikkor 70-300mm f/4.5-5.6E ED VR for full-frame D-SLR cameras. The lens employs a stepping motor to the AF drive to realise high speed and quiet shutter release, also important to videography. The lens is equipped with optical vibration reduction (VR) function giving about 4.5-step advantage. It is also equipped with a SPORT mode to photograph fast-moving subjects. The lens consists of 18 elements in 14 groups, including one ED (Extra-low Dispersion) element to correct chromatic aberrations. The closest shooting distance is 1.2m for the entire zoom. The lens is also designed as ‘antidust and antisplash’. The maximum diameter is 80.5mm, length 146m and weighs about 680g. Suggested list price: 94,000 yen.